LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
Oncotarget | September 29, 2015 | Volume: 6 | Issue: 29 | Pages: 27359-27377
10.18632/oncotarget.4751
| PMID 26318293